Insufficient scRNA-seq data for expression of PNPLA1 at single-cell level.
Insufficient scRNA-seq data for expression of PNPLA1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 68% | 128.07 | 243 / 359 | 28% | 0.60 | 80 / 286 |
kidney | 63% | 121.20 | 56 / 89 | 23% | 0.53 | 209 / 901 |
skin | 72% | 1276.17 | 1303 / 1809 | 7% | 0.40 | 34 / 472 |
spleen | 78% | 68.02 | 189 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 77% | 299.24 | 716 / 929 | 0% | 0 | 0 / 0 |
lung | 22% | 15.19 | 127 / 578 | 18% | 0.49 | 204 / 1155 |
intestine | 11% | 11.18 | 110 / 966 | 28% | 0.63 | 145 / 527 |
esophagus | 0% | 0.28 | 6 / 1445 | 35% | 1.29 | 64 / 183 |
adrenal gland | 13% | 10.54 | 34 / 258 | 13% | 0.93 | 31 / 230 |
bladder | 0% | 0 | 0 / 21 | 24% | 0.77 | 123 / 504 |
uterus | 1% | 0.81 | 2 / 170 | 16% | 0.52 | 74 / 459 |
tonsil | 0% | 0 | 0 / 0 | 11% | 0.29 | 5 / 45 |
adipose | 2% | 2.60 | 29 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 2% | 0.04 | 4 / 178 |
breast | 0% | 0 | 0 / 459 | 2% | 0.05 | 17 / 1118 |
brain | 1% | 0.48 | 23 / 2642 | 0% | 0.01 | 1 / 705 |
blood vessel | 1% | 1.09 | 13 / 1335 | 0% | 0 | 0 / 0 |
thymus | 0% | 0.06 | 1 / 653 | 0% | 0.01 | 3 / 605 |
ovary | 1% | 0.39 | 1 / 180 | 0% | 0 | 0 / 430 |
liver | 0% | 0 | 0 / 226 | 0% | 0.01 | 2 / 406 |
prostate | 0% | 0.30 | 1 / 245 | 0% | 0 | 0 / 502 |
heart | 0% | 0.11 | 2 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.50 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0019433 | Biological process | triglyceride catabolic process |
GO_0055088 | Biological process | lipid homeostasis |
GO_0106342 | Biological process | omega-hydroxyceramide biosynthetic process |
GO_0046513 | Biological process | ceramide biosynthetic process |
GO_0005811 | Cellular component | lipid droplet |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0004806 | Molecular function | triglyceride lipase activity |
GO_0106341 | Molecular function | omega-hydroxyceramide transacylase activity |
GO_0016747 | Molecular function | acyltransferase activity, transferring groups other than amino-acyl groups |
GO_0030280 | Molecular function | structural constituent of skin epidermis |
Gene name | PNPLA1 |
Protein name | Omega-hydroxyceramide transacylase (EC 2.3.1.296) (Patatin-like phospholipase domain-containing protein 1) Patatin like phospholipase domain containing 1 |
Synonyms | |
Description | FUNCTION: Omega-hydroxyceramide transacylase involved in the synthesis of omega-O-acylceramides (esterified omega-hydroxyacyl-sphingosine; EOS), which are extremely hydrophobic lipids involved in skin barrier formation . Catalyzes the last step of the synthesis of omega-O-acylceramides by transferring linoleic acid from triglycerides to an omega-hydroxyceramide . Omega-O-acylceramides, are required for the biogenesis of lipid lamellae in the stratum corneum and the formation of the cornified lipid envelope which are essential for the epidermis barrier function . These lipids also play a role in keratinocyte differentiation (By similarity). May also act on omega-hydroxylated ultra-long chain fatty acids (omega-OH ULCFA) and acylglucosylceramides (GlcEOS) (By similarity). . |
Accessions | ENST00000636260.2 Q8N8W4 A0A1B0GW56 ENST00000394571.3 [Q8N8W4-1] A0A0C4DG24 ENST00000388715.7 [Q8N8W4-2] ENST00000312917.9 [Q8N8W4-3] ENST00000457797.5 |